Indaptus Therapeutics Analyst Ratings
Indaptus Therapeutics Analyst Ratings
While ratings are subjective and will change, the latest Indaptus Therapeutics (INDP) rating was a reiterated with a price target of $0.00 to $12.00. The current price Indaptus Therapeutics (INDP) is trading at is $3.95, which is within the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/20/2023 | 203.8% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 08/15/2023 | 203.8% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 08/11/2023 | 203.8% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 08/08/2023 | 203.8% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/04/2023 | 203.8% | HC Wainwright & Co. | → $12 | Reiterates | → Buy |
| 03/20/2023 | 203.8% | HC Wainwright & Co. | $15 → $12 | Maintains | Buy |
| 03/08/2023 | 279.75% | HC Wainwright & Co. | → $15 | Reiterates | → Overweight |
| 02/08/2023 | 279.75% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
| 01/31/2022 | 279.75% | HC Wainwright & Co. | → $15 | Assumes | → Buy |
| 10/19/2021 | 305.06% | Maxim Group | → $16 | Upgrades | Hold → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 09/20/2023 | 203.8% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 2023年08月15日 | 203.8% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 2023年08月11日 | 203.8% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 2023/08/08 | 203.8% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 05/04/2023 | 203.8% | HC Wainwright公司 | →$12 | 重申 | →购买 |
| 03/20/2023 | 203.8% | HC Wainwright公司 | $15→$12 | 维护 | 买 |
| 03/08/2023 | 279.75% | HC Wainwright公司 | →$15 | 重申 | →超重 |
| 02/08/2023 | 279.75% | HC Wainwright公司 | →$15 | 重申 | →购买 |
| 2022年1月31日 | 279.75% | HC Wainwright公司 | →$15 | 假设 | →购买 |
| 10/19/2021 | 305.06% | Maxim集团 | →$16 | 升级 | 持有→购买 |
What is the target price for Indaptus Therapeutics (INDP)?
Indaptus Treeutics(INDP)的目标价格是多少？
The latest price target for Indaptus Therapeutics (NASDAQ: INDP) was reported by HC Wainwright & Co. on September 20, 2023. The analyst firm set a price target for $12.00 expecting INDP to rise to within 12 months (a possible 203.80% upside). 8 analyst firms have reported ratings in the last year.
HC Wainwright&Co.于2023年9月20日报道了Indaptus治疗公司(纳斯达克代码：INDP)的最新目标价。这家分析公司将目标价定为12美元，预计Indp将在12个月内升至(可能上涨203.80%)。去年有8家分析公司公布了评级。
What is the most recent analyst rating for Indaptus Therapeutics (INDP)?
Indaptus Treeutics(INDP)的最新分析师评级是多少？
The latest analyst rating for Indaptus Therapeutics (NASDAQ: INDP) was provided by HC Wainwright & Co., and Indaptus Therapeutics reiterated their buy rating.
对Indaptus治疗公司(纳斯达克代码：INDP)的最新分析师评级由HC Wainwright&Co.提供，Indaptus治疗公司重申了他们的买入评级。
When is the next analyst rating going to be posted or updated for Indaptus Therapeutics (INDP)?
Indaptus Treeutics(INDP)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Indaptus Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Indaptus Therapeutics was filed on September 20, 2023 so you should expect the next rating to be made available sometime around September 20, 2024.
分析师在进行了广泛的研究后得出股票评级，其中包括查阅公共财务报表，与Indaptus Treeutics的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Indaptus治疗公司的上一次评级是在2023年9月20日提交的，所以你应该预计下一次评级将在2024年9月20日左右的某个时候提供。
Is the Analyst Rating Indaptus Therapeutics (INDP) correct?
分析师对Indaptus Treeutics(INDP)的评级正确吗？
While ratings are subjective and will change, the latest Indaptus Therapeutics (INDP) rating was a reiterated with a price target of $0.00 to $12.00. The current price Indaptus Therapeutics (INDP) is trading at is $3.95, which is within the analyst's predicted range.
虽然评级是主观的，并将发生变化，但最新的Indaptus治疗公司(INDP)评级被重申，目标价在0.00美元至12.00美元之间。Indaptus Treateutics(INDP)目前的交易价格为3.95美元，在分析师的预测范围内。
